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Abstract 
Exercise is an effective intervention for prevention and treatment of type 2 diabetes. Skeletal muscle 
combines multiple signals contributing to the beneficial effects of exercise on cardiometabolic health. 
Inorganic nitrate increases exercise efficiency, tolerance and performance. The transcriptional regulator 
peroxisome proliferator-DFWLYDWHGUHFHSWRUȖFRDFWLYDWRUĮ3*&ĮFRRUGLQDWHVWKHH[HUFLVH-stimulated 
skeletal muscle fiber-type switch from glycolytic fast-twitch (type IIb) to oxidative slow-twitch (type I) 
and intermediate (type IIa) fibers; an effect reversed in insulin resistance and diabetes. We find that 
QLWUDWHLQGXFHV3*&ĮH[SUHVVLRQDQGDVZLWFKWRZDUGVW\SH,DQG,,DILEHUVLQUDWPXVFOHDQG myotubes 
in vitro1LWUDWHLQGXFHVWKHUHOHDVHRIH[HUFLVH3*&Į-dependent myokine FNDC5/irisin, DQGȕ-
aminoisobutyric acid from myotubes, and muscle in rats and humans. Both exercise and nitrate 
VWLPXODWHG3*&Į-PHGLDWHGȖ-aminobutyric acid (GABA) secretion from muscle. Circulating GABA 
concentrations were increased in exercising mice and nitrate-treated rats and humans, thus, GABA may 
IXQFWLRQDVDQH[HUFLVH3*&Į-mediated myokine-like small molecule. Moreover, nitrate increased 
circulating growth hormone levels in humans and rodents. Nitrate induces physiological responses that 
mimic exercise training and may underlie the beneficial effects of this metabolite on exercise and 
cardiometabolic health. 
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Inorganic nitrate was considered a biologically inert metabolic end-product of nitric oxide (NO) 
metabolism (1). However, the discovery of the nitrate-nitrite-NO pathway in mammals, in which nitrate 
is reduced to the ubiquitous signaling molecule NO, has led to renewed interest in the physiological role 
of nitrate (2; 3). The discovery of anti-obesity and anti-diabetic effects of nitrate in rodents, has 
stimulated interest in nitrate as a therapeutic for the metabolic syndrome (4; 5). 
 
NO has multiple effects on skeletal muscle phenotypes including mitochondrial biogenesis and fatty 
DFLGȕ-oxidation, glucose homeostasis, and contraction and fatigue (6; 7). Augmenting the nitrate-nitrite-
NO pathway may be a means of increasing bioavailable NO to improve muscle function. Systemic 
concentrations of nitrate can be enhanced through dietary consumption of nitrate-rich foods such as 
green leafy vegetables (8). Following studies in rodents and humans, identifying that nitrate can improve 
exercise efficiency (9),  tolerance (10), and performance (11), nitrate has gained popularity as a 
nutritional exercise supplement.  
 
We recently demonstrated that dietary nitrate increases peroxisome proliferator-DFWLYDWHGUHFHSWRUȖ
coactivator-Į3*&Į expression in white adipose tissue (WAT) (12),QVNHOHWDOPXVFOH3*&ĮLVD
master transcriptional regulator of the adaptive response to exercise (13). 7UDQVJHQLF3*&ĮH[SUHVVLRQ
in skeletal muscle increases exercise performance and transcription of genes for oxidative slow-twitch 
type I and intermediate type IIa fibers (13). (QGXUDQFHH[HUFLVHWUDLQLQJSDUWLDOO\WKURXJK3*&Į 
transcriptional activity, also increases slow-twitch type I and intermediate type IIa myosin heavy chains 
(MYH) within skeletal muscle (13; 14). These type I and IIa fibers are characterized by high 
mitochondrial content and facilitate resistance to fatigue (15). Skeletal muscle also mediates many of the 
signals contributing to the beneficial effects of exercise on health (16)5HFHQWO\3*&ĮZDVLGHQWLILHG
as a mediator of several non-muscle metabolic effects of exercise through the regulation of exercise-
dependent myokine signals (17; 18).  
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Exercise is an effective intervention for both the prevention and treatment of type 2 diabetes mellitus 
(T2DM) (19). Diabetic myopathy, characterized by reduced muscle functional capacity, atrophy and a 
glycolytic fiber-type, is a major diabetic complication (20). Furthermore, the proportion of type I fibers 
in muscle is positively correlated with systemic insulin sensitivity (21); and decreased levels of type I 
fibers are associated with insulin resistant states including T2DM (22). Therefore, we employ 
transcriptional, protein and metabolomic analyses to determine the effects of inorganic nitrate on 
markers of the adaptive response to exercise in skeletal muscle, including fiber-type phenotype, and 
3*&ĮDQGH[HUFLVH-dependent myokine production. We demonstrate that nitrate induces physiological 
adaptations both in skeletal muscle, and systemically, that mimic exercise training and may underlie the 
beneficial effects of the small molecule on exercise tolerance, efficiency and performance, and 
cardiometabolic risk. 
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Research Design and Methods 
Animal Experimentation. Male Wistar rats (6 weeks old) (269 ± 2 g) (Charles River) were weight 
matched and received either distilled water containing NaCl (0.7mM NaCl; n = 9) or water containing 
sodium nitrate (NaNO3) (0.7 mM NaNO3; n = 9) (Ultra-pure, Sigma-Aldrich) ad libitum for 18 days.  
Animals were housed in conventional cages at room temperature with a 12-hour/12-hour light/dark 
photoperiod. Morphological parameters are given in Table S1. 
 
Muscle-VSHFLILF3*&ĮWUDQVJHQLFPLFHZHUHJHQHUDWHGDQGPDLQWDLQHGDVSUHYLRXVO\GHVFULEHG(17). 
For the exercise experiments, 12-week-old B6 mice (Jackson Laboratory) were conditioned with 3 
weeks of free wheel running (n = 6) (14; 17; 18). Controls were age matched sedentary littermates (n = 
6). 
All procedures were carried out in accordance with U.K. Home Office protocols by a personal license 
holder. 
 
Blood and Tissue Collection. Rats and mice were euthanized (sodium pentobarbital 200 mg/ml, 
Vétoquinol UK). Blood was collected by cardiac puncture and centrifuged to obtain plasma. Soleus, 
gastrocnemius or quadriceps muscle were removed and flash frozen in liquid nitrogen.  
 
C2C12 Culture. C2C12 myoblasts were grown to confluence in DMEM supplemented with 10% FBS. 
Differentiation was induced with DMEM containing 10% horse serum (HS, Sigma-Aldrich) and 850 nM 
insulin. During the 6 day differentiation, cells were cultured with either saline (control), 25 ȝ01D123, 
RUȝ01D123 or, during the sodium nitrite studies (NaNO2), with saline (control), 500 nM NaNO2, 
ȝ01D122 RUȝ01D122 (Ultra-pure, Sigma-Aldrich). Differentiation of C2C12 cells is 
unaffected by NaNO3 (23). Pharmacological agent studies utilized 2,2-Bipyridyl (100 µM), 2-Phenyl-
4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide 37,2ȝ0NG-nitro-L-arginine methyl ester (L-
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NAME) (1 mM), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (2'4ȝ0*:Q0DQG
sildenafil (1 µM) (Sigma-Aldrich). Cells were treated with 2,2-Bipyridyl, PTIO, L-NAME, or ODQ 
with and wLWKRXWȝ01D123. NaNO3 and pharmacological agents were added at day 1 of 
differentiation and maintained for 6 days with the exception of 2,2-Bipyridyl which was added 6h prior 
to the end of the experiment. 
 
Primary Adipocyte Culture. Primary adipose stromal vascular cells were isolated, cultured and 
differentiated into adipocytes according to published methods (12; 17).  During differentiation, cells 
were cultured with either VDOLQHFRQWUROȝ01D123 (Ultra-pure, Sigma-Aldrich), 125 ng/ml Irisin 
%LR9LVLRQ,QFRUQJPO,ULVLQDQGȝ01D123. 
 
Small Interfering RNA PGC1Į Knockdown. FlexiTube small interfering RNA (siRNA) against 
3*&Į, AllStars negative control siRNA, and HiPerFect Transfection Reagent were purchased from 
QIAGEN. C2C12 myotubes were transfected per the manufactureU¶VLQVWUXFWLRQVQJVL51$ ȝ/
transfection reagent per well, 10 nmol/L final siRNA concentration) on days 2 and 4 of differentiation. 
 
Metabolite Extraction. Metabolites were extracted from soleus muscle of nitrate treated rats, 
gastrocnemius and quadriceps muscle of exercise trained mice, plasma of nitrate treated rats, MCK-
3*&ĮWUDQVJHQLFPLFHH[HUFLVHWUDLQHGmice and nitrate supplemented human volunteers, nitrate 
WUHDWHGDQG33$5įDJRQLVWWUHDWHG&&P\RWXEHVDQGFXOWXUHPHGLDas previously described (12).  
 
Gene Expression. Total RNA extraction from soleus and gastrocnemius muscle of nitrate treated rats, 
nitrate and irisin treated adipocytes and QLWUDWH*:33$5įDJRQLVW2,2-Bipyridyl, PTIO, L-NAME, 
ODQ and sildenafil treated myocytes, cDNA conversion and quantitative RT-PCR was performed as per 
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published protocols (17). All data were normalized to 18SrRNA (mouse primary adipocytes, C2C12 
P\REODVWVRU5/3/UDWPXVFOHDQGTXDQWLWDWLYHPHDVXUHVREWDLQHGXVLQJWKHǻ-ǻ-CT method.  
 
Protein Analysis. 3*&ĮMYH7and MYH2 were analyzed in nitrate treated rat soleus. Irisin was 
analyzed in nitrate supplemented human and rat plasma and nitrate, GW742 and sildenafil treated 
myocyte media. Rat and human growth hormone was measured in nitrate supplemented rat and human 
plasma, respectively. For all measurements analysis was performed using ELISA as per the 
PDQXIDFWXUHU¶VLQVWUXFWLRQV3*&Į.LW6(+5D0<+.LW6('5D&ORXG-Clone Corp. 
Houston, TX, USA) (MYH2 Kit, ABIN2093055, antibodies-online GmbH, Aachen, Germany) (Irisin 
Kit. K4761-100, BioVision Inc. Milpitas, CA, USA) (Rat Growth Hormone Kit E-EL-R0029, 
Elabscience, Beijing, China) (Human Growth Hormone Kit EK0578, Boster Biological Technology Co., 
Pleasanton, CA, USA).  
 
Immunohistochemistry. Soleus and gastrocnemius cross sections from nitrate treated rats were 
SUHSDUHGDWDWKLFNQHVVRIȝPXVLQJDFU\RVWDW,PPXQRKLVWRFKHPLFDOVWDLQLQJDQGILEHU-type 
assessment was performed according to published methods (24). Antibodies were type I fiber, 
monoclonal antimyosin (skeletal, slow; clone NOQ7.5.4D; Sigma-Aldrich) and type II fiber, 
monoclonal antimyosin (skeletal, fast; alkaline phosphatase conjugate; clone MY-32; Sigma-Aldrich). 
 
Gas Chromatography-Mass Spectrometry (GC-MS). GC-MS and data analysis were performed on 
metabolites from nitrate treated rat soleus using the methods described previously (12).  
 
Plasma Nitrate. Plasma nitrate from rats and humans was measured as described previously (12).  
 
Liquid Chromatography-Mass Spectrometry (LC-MS). LC-MS analysis was performed on 
metabolites from the plasma of nitrate supplemented humans and rats, and MCK-3*&ĮPLFH, soleus of 
9 
 
nitrate treated rats, nitrate and GW742 treated myotubes and culture media, and the gastrocnemius and 
quadriceps muscle of exercise trained mice using a 4000 QTRAP mass spectrometer (Applied 
Biosystems/Sciex), coupled to an Acquity UPLC (Waters Corporation, Manchester, UK) according to 
published methods (12; 17).  
 
Human Study. A cross-over, randomized, placebo controlled, double-blind clinical trial of participants 
given either concentrated beetroot juice (2x70ml/day, 12.0 mmoles of nitrate) or nitrate-depleted 
beetroot juice (placebo, 2x70ml/day, 0.003 mmoles of nitrate) for 7 days was conducted. Nineteen 
participants completed the study. Mean age was 64.7 ± 3.0 years. Participants were healthy, non-obese 
volunteers (For BMI, sex distribution and age see table S2). Exclusion criteria included high resting 
blood pressure (Systolic>180mmHg and/or Diastolic >110mmHg), high physical activity level (>15000 
steps per day), a weight change of more than 3.0kg in the last 2 months, diagnosis of metabolic, 
cardiovascular and inflammatory conditions or diabetes. Participants were randomized to: 1) Nitrate 
supplementation (beetroot juice 2x70ml/day, containing ׽12.0 mmoles nitrate) or 2) Placebo (nitrate-
depleted beetroot juice 2x70ml/day, containing ׽0.003 mmoles nitrate) for 7 days. Nitrate-depleted 
beetroot juice was prepared according to published methods (25). After a 7 day wash-out period, the 
second 7-day intervention was conducted. Blood serum was collected at baseline and termination of 
each intervention and aliquoted. Participants were fasted for 12 hours prior, and avoided exercise 3 days 
prior, to each visit. Serum NOx concentrations were measured using GC-MS as previously described 
(26).  The trial was approved by the North of Scotland Research Ethics committee (14/NS/0061).  
 
Statistical Analyses. Error bars represent standard error of the mean. P-values were calculated by either 
t-test, one-way or two-ZD\$129$DVVWDWHGZLWKD7XNH\¶Vpost-hoc test. Human study data was 
analyzed using paired t-test. 
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Results 
Nitrate Promotes Fiber-type Switching in the Oxidative Soleus Muscle  
3*&Į activation may underlie the effects of nitrate on exercise; therefore we analyzed the effect of 
QLWUDWHRQ3*&ĮH[SUHVVLRQLQVNHOHWDOPXVFOHin vivo. Wistar rats were treated with 0.7mM NaCl or 
0.7 mM NaNO3 in drinking water for 18 days. Plasma nitrate concentrations increased from 7.1 ± 1.0 
ȝ0LQ1D&OWUHDWHGFRQWUROUDWVWRȝ0LQUDWVWUHDWHGZLWKP01D123 3:DWHU
and food intake was not significantly different between groups (Table S1LWUDWHLQFUHDVHG3*&Į
expression in the soleus muscle of rats (Fig. 1A).  
 
Hypoxia-LQGXFLEOHIDFWRUĮ+,)ĮLVDVNHOHWDOPXVFOH-VHOHFWLYH3*&ĮWUDQVFULSWLRQDOWDUJHWWKDWLV
positively regulated by exercise and has a key role in muscle function (14)+,)Į expression was 
increased in the soleus of nitrate treated rats (Fig. 1B3*&ĮDQG+,)ĮFRRUGLQDWHWRLQGXFHfiber-
type switching from glycolytic type IIb fibers to intermediate type IIa and oxidative type I fibers as an 
adaptation to exercise training (13; 14). Nitrate also increased the expression of Myosin Heavy Chain 7 
(MYH7), a fundamental constituent of type I muscle fiber, and Myosin Heavy Chain 2 (MYH2), an 
important component of type IIa fibers (Fig. 1C). Concomitantly, the expression of Myosin Heavy 
Chain 4 (MYH4), specific to fast-twitch type IIb fibers, was decreased. Expression of additional genes 
characteristic of slow-twitch muscle fibers such as Myoglobin (Mb) and Calmodulin2 (CALM2) was 
increased in the soleus by nitrate treatment (Fig. 1C). 
 
To determine whether transcriptional changes in fiber-type specific genes translated into corresponding 
changes in protein levelsWKHFRQFHQWUDWLRQVRI3*&Į0<+DQG0<+SURWHLQLQWKHVROHXVRI
nitrate treated rats were analyzed XVLQJ(/,6$1LWUDWHLQFUHDVHGWKHSURWHLQFRQFHQWUDWLRQRI3*&Į
(Fig. 1D), MYH7 and MYH2 (Fig. 1E and 1F). 
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An increase in type I fibers drives a switch in energetic fuel usage away from glycolytic metabolism. 
Therefore, we employed GC-MS-based metabolomics to analyze glycolytic intermediates from soleus 
muscle of nitrate treated rats. Nitrate decreased the concentrations of the key glycolytic intermediates 
glucose-6-phosphate (Fig. 1G) and 3-phosphoglycerate (Fig. 1H).  
 
Consistent with these data, immunohistochemical analysis of soleus muscle from control and nitrate-
treated rats confirms nitrate induces a decrease in constituent type II fibers and increase in type I fibers 
(Fig. 1I and 1J).  
 
Nitrate Promotes Fiber-type Switching in the Glycolytic Gastrocnemius Muscle 
To establish whether the effects in slow-twitch soleus were muscle type specific, the expression of genes 
determining fiber-type were examined in the mixed fiber-type gastrocnemius muscle of nitrate treated 
UDWV1LWUDWHLQFUHDVHG3*&ĮDQG+,)Į expression in the gastrocnemius (Fig. 2A). The expression of 
the type I and type IIa fiber markers MYH7, Mb and MYH2 were increased to a greater extent in 
gastrocnemius than in soleus following nitrate treatment; possibly representing the greater capacity for 
gastrocnemius to undergo a switch towards oxidative fiber-types compared to the already highly 
oxidative soleus. Nitrate also decreased the expression of the type IIb fiber component, MYH4 (Fig. 
2A). 
 
Histological examination of the gastrocnemius muscle of nitrate treated rats confirms an increase in type 
I muscle fibers and a concomitant decrease in type II muscle fibers (Fig. 2B and 2C).    
 
Taken together, these data suggest that nitrate is an inducer of muscle fibre-type switching, increasing 
the proportion of oxidative slow-twitch fibers to fast-twitch glycolytic fibers within muscle.   
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Nitrate Promotes an Exercise Training-like Phenotype in Myotubes via a NO-Mediated 
Mechanism   
We next focused on establishing the mechanism underlying nitrate-induced fiber-type switching. C2C12 
mouse myoblasts were differentiated into myotubes in the presence of nitrate to establish whether nitrate 
functions directly at the muscle to increase type I fiber-associated gene expression. Under normoxic 
FRQGLWLRQV+,)ĮSURWHLQLVK\GUR[\ODWHGE\ prolyl hydroxylase domain containing enzymes (PHDs), 
ubiquitinated and degraded by the proteasome (27)+,)ĮSURWHLQPXVWEHVWDELOL]HGIROORZLQJ
3*&Į-induced expression, to activate fiber-type switching (14); therefore the myotubes were also 
treated for 6 hours with 2,2-ELS\ULG\OWRLQDFWLYDWH3+'VDQGVWDELOL]H+,)Į([SUHVVLRQRI3*&ĮZDV
significantly and similarly increased in myotubes treated with either nitrate alone or nitrate in 
combination with 2,2-bipyridyl (Fig. 3A)ROORZLQJ+,)ĮVWDELOL]DWLRQWUHDWPHQWRIP\RWXEHVZLWK
nitrate increased expression of type I and type IIa fiber-type genes and suppressed expression of type IIb 
fiber markers (Fig. 3B,QWHUHVWLQJO\QLWUDWHLQWKHDEVHQFHRIDGGLWLRQDO+,)ĮVWDELOL]DWLRQDOVR
increased expression of type I and type IIa fiber-type markers, albeit to a lesser extent than nitrate in 
combination with 2,2-bipyridyl (Fig. 3B). 
 
NO can be generated directly from nitrate via non-enzymatic processes and the enzymatic nitrate-nitrite-
NO pathway in vivo (2; 12)12LQFUHDVHV3*&Į expression in skeletal muscle and inhibits HIF 
complex prolyl hydroxylases, stabilizing the HIF complex (6; 28). Therefore, C2C12 mouse myotubes 
were treated with a range of nitrate doses during differentiation (25 µM and 500 µM) to determine 
whether nitrate-induced fiber-type switching would occur in a dose-dependent manner, in the absence of 
additional HIF stabilization. The 500 µM nitrate dose corresponds to plasma concentrations in mice 
exhibiting improved metabolic phenotypes when chronically dosed with 0.1 mmol/kg NaNO3 (4). 
Nitrate treatment alone significantly increased 3*&ĮDQG+,)Į expression (Fig. 3C). Also increased 
in expression in nitrate-treated myotubes were type I fiber-associated genes. The expression of type IIb 
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fiber-associated genes was decreased by nitrate. These data suggest nitrate-mediated induction of fiber-
type gene expression occurs in skeletal muscle and does not require additional HIF stabilization. 
 
We next examined whether the nitrate-stimulated expression of type I fiber-associated genes was NO-
dependent. Myotubes were differentiated in the presence of nitrate and the NO scavenger PTIO. NO 
sequestration by PTIO abrogated nitrate-induced expression of type I and type IIa fiber-associated genes 
(Fig. 3C). Nitrite is the initial reduction product in the nitrate-nitrite-NO pathway and was also found to 
increase expression of type I fiber-associated genes in myotubes (Fig. 3D). The effect of nitrite was also 
found to be abrogated by NO sequestration (Fig. S1) 
 
To eliminate the canonical L-arginine-nitric oxide synthase-NO pathway as the source of NO 
stimulating the fiber-type switching effect of nitrate, myotubes were co-treated with nitrate and the NOS 
inhibitor L-NAME. NOS inhibition did not prevent nitrate-stimulated expression of type I fiber-
associated genes (Fig. S2). Therefore, the nitrate/NO-mediated fiber-type switching effect is 
independent of NOS.  
 
Nitrate may augment the fiber-type switching effect observed in muscle following exercise training (29); 
therefore myotubes were treated with an exercise mimetic, the peroxisome proliferator-activated 
UHFHSWRUį33$5įDJRQLVW*:(30), both alone and in combination with nitrate. Co-treatment of 
myotubes with nitrate and GW742 had an additive effect on type I fiber-associated gene expression (Fig. 
3E). Thus, nitrate may augment muscle fiber-type switching in an exercise training background.     
 
Nitrate-Induced Muscle Fiber-type Switching LVPHGLDWHGE\3*&Į  
The LQFUHDVHVLQ3*&ĮH[SUHVVLon and protein concentration in skeletal muscle and myotubes likely 
mediates the nitrate-induced fiber-type switch. Therefore, WKHH[SUHVVLRQRI3*&Į in C2C12 myotubes 
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was knocked down by ׽60% using siRNA (Fig. 4A). Reduced 3*&Į expression abrogated the nitrate-
induced expression of type I and type IIa fiber genes in myotubes (Fig. 4B). 
 
Nitrate-Mediated Muscle Fiber-type Switching Functions through Soluble Guanylyl Cyclase and 
is Enhanced by Sildenafil  
We next sought to identify the downstream signaling cascade mediating nitrate/NO-induced muscle 
fiber-type switching. The principal downstream effector of NO is cGMP. NO activates cGMP signaling 
through stimulation of soluble guanylyl cyclase (sGC). The inhibitor of sGC, ODQ, abrogated the 
nitrate-induced expression of type I fiber-associated genes in myotubes (Fig. 4C).  
 
The secondary messenger cGMP is degraded by Cyclic Nucleotide Phosphodiesterase 5 (PDE5). 
Interestingly, the expression of PDE5 is increased in nitrate treated myotubes, and may represent a 
counter-regulatory response (Fig. 4D). The PDE5 inhibitor, sildenafil, increases 3*&Į expression in 
myocytes, reduces muscle fatigue and improves exercise efficiency (31; 32). Therefore, we 
hypothesized that PDE5 inhibition would enhance nitrate-mediated fiber-type switching. The expression 
of type I muscle fiber-associated genes in myotubes was increased by sildenafil; an effect further 
enhanced by co-treatment with nitrate (Fig. 4E).   
 
1LWUDWH$FWLYDWHV6HFUHWLRQRIWKH3*&Į([HUFLVH-dependent Myokine FNDC5/irisin  
Exercise-conditioned skeletal muscle is the source of hormone-like signals, known as myokines, which 
participate in organ cross-talk (17; 18). The myokine, fibronectin type III domain-containing 5/irisin 
)1'&LULVLQLVH[SUHVVHGDQGVHFUHWHGLQD3*&Į-dependent manner (18). As nitrate increases 
3*&Į expression in skeletal muscle, we asked whether the nitrate-induced exercise training-like effect 
in myotubes increased irisin production and secretion. Nitrate increased FNDC5 expression in myotubes 
in an NO-dependent manner (Fig. 5A). Interestingly, FNDC5 expression in myotubes was increased by 
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PDE5 inhibition using sildenafil and further increased by co-treatment with both nitrate and sildenafil 
(Fig. 5B). The secretion of irisin from myotubes into serum-free culture media was increased following 
nitrate treatment, an effect also observed following treatment of myotubes with an exercise mimetic, 
GW742 (30) (Fig. 5C).  
 
Having identified nitrate-stimulated expression and secretion of irisin from myotubes in vitro, we 
investigated whether this effect was translated in vivo. FNDC5 expression in the soleus (Fig. 5D) and 
gastrocnemius (Fig. 5E) of nitrate treated rats was increased compared to control animals. Increased 
irisin expression in the soleus and gastrocnemius muscles was reflected in a significant increase in the 
plasma irisin concentration of nitrate treated rats (Fig. 5F). 
 
We then asked whether the effect of nitrate on plasma irisin concentrations in rodents translated into 
humans. A cross-over, randomized, placebo controlled, double-blind clinical trial of participants given 
either concentrated beetroot juice (2x70ml/day, 12.0 mmoles of nitrate) or nitrate-depleted beetroot juice 
(placebo, 2x70ml/day, 0.003 mmoles of nitrate) for 7 days was implemented (Table S2). Following a 7 
day wash-out period, participants were crossed-over to the reciprocal intervention. Nitrate treatment 
significantly increased both the fasted serum nitrogen oxides (NOx) (Fig. 5G) and serum irisin 
concentrations (Fig. 5H) of the participants.  
 
Nitrate and Irisin Function Additively to Induce Adipocyte ³%URZQLQJ´ 
Irisin induces a brown adipose-OLNHSKHQRW\SHLQ:$7GHSRWVLQD33$5Į-dependent manner (18). 
Nitrate activates WAT browning YLDD33$5Į-independent nitrate-NO-cGMP signaling axis (12). Given 
their distinct signaling mechanisms, we hypothesized that irisin and nitrate may have an additive effect 
on brown adipocyte-associated gene expression in primary adipocytes. Murine primary adipocytes 
treated with a combination of both irisin and nitrate exhibited a greater expression of brown adipocyte-
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associated genes than adipocytes treated with irisin or nitrate alone (Fig. S3). Therefore nitrate may 
enhance the exercise-induced, irisin-mediated browning of WAT.      
 
1LWUDWH,QGXFHVWKH6HFUHWLRQRIWKH3*&Į([HUFLVH-dependent Myokine-like Small Molecule ȕ-
aminoisobutyric Acid  
Exercise stimulates WKHUHOHDVHRIȕ-aminoisobutyric acid (BAIBA) from skeletal muscle (17). BAIBA is 
an exercise training anG3*&Į-dependent myokine-like small molecule signal with effects on both 
WAT and hepatic metabolism. Therefore, we employed LC-MS to profile metabolites in nitrate-treated 
myotubes and in serum-free conditioned cell media. Nitrate significantly increased the intracellular (Fig. 
6A) and extracellular BAIBA concentrations (Fig. 6B). Nitrate also increased the expression of BAIBA 
biosynthetic enzymes acyl-CoA dehydrogenase short chain (ACADS) and hydroxyacyl-CoA 
dehydrogenase (HADHA) in myotubes in an NO-dependent manner (Fig. 6C).   
 
We next used LC-MS to profile the metabolites in soleus muscle and plasma from nitrate treated rats. 
Nitrate significantly increased the BAIBA concentration (Fig. 6D) and the expression of BAIBA 
biosynthetic genes, ACADS and HADHA, in the soleus muscle of the nitrate treated rats (Fig. 6E). 
Plasma BAIBA concentration was also increased by nitrate treatment (Fig 6F).     
 
Nitrate Increases Plasma Ȗ-Aminobutyric Acid Concentrations in Rats and Humans  
Interestingly, LC-MS profiling identified an increase in the plasma Ȗ-aminobutyric acid (GABA) 
concentration of nitrate treated rats (Fig. 7A), with a concomitant decrease in the GABA metabolic 
precursor glutamine (Fig. 7B). This observation was reproduced in humans, with 7 day nitrate 
supplementation increasing serum GABA (Fig. 7C) and decreasing the serum glutamine concentration 
(Fig. 7D). GABA is also HQULFKHGLQWKHPHGLDRIWUDQVJHQLF3*&Į-expressing myocytes (17) and in 
the muscle of mice with muscle-VSHFLILFWUDQVJHQLFH[SUHVVLRQRI3*&Į0&.-3*&Į(33). We used 
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LC-MS to analyze the plasma GABA concentrations of MCK-3*&ĮPLFH. The plasma GABA 
conceQWUDWLRQZDVVLJQLILFDQWO\LQFUHDVHGE\3*&Į forced expression in muscle in vivo (Fig. 7E). 
 
6LQFHQLWUDWHLQFUHDVHG3*&Į expression in myotubes, we applied LC-MS profiling to serum-free 
media, conditioned for 24 h on myotubes treated with nitrate or the exercise mimetic GW742 (30). 
GABA was significantly enriched in the media of both nitrate and GW742 treated myotubes (Fig. 7F). 
The intracellular GABA concentration was also increased in nitrate treated myotubes (Fig. 7G).  
 
As GABA was increased in myocyte media E\QLWUDWHWUHDWPHQWDQGE\IRUFHG3*&ĮH[SUHVVLRQDQG
was increased in the plasma of nitrate treated rats and humans, we examined whether concentrations of 
GABA were increased following exercise training in the plasma (Fig. 7H), gastrocnemius (Fig 7I) and 
quadriceps (Fig 7J) muscles of mice conditioned with 3 weeks free wheel running (17; 18). Exercise 
training increased the GABA concentration in both muscle and plasma. TKHVHGDWDVXJJHVWWKDW3*&Į
stimulates the biosynthesis and release of GABA from skeletal muscle during exercise training and 
nitrate treatment. 
 
Dietary Nitrate Increases Plasma Growth Hormone Concentrations of Rats and Humans 
Long-term exercise training, NO, and plasma GABA increase the plasma concentration of growth 
hormone (34-36). Nitrate increased the circulating growth hormone concentrations of nitrate treated rats 
(Fig. 7K) and nitrate supplemented humans (Fig. 7L). Together, these studies demonstrate that nitrate 
treatment mimics several physiological effects of exercise training both on skeletal muscle and 
systemically, and suggest GABA as a novel, 3*&Į-mediated, exercise and nitrate-stimulated myokine-
like small molecule signal.   
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Discussion 
Exercise training demonstrates significant anti-diabetic effects (19). The ubiquitous dietary anion, 
nitrate, improves submaximal and high intensity exercise efficiency (9), tolerance (10), and performance 
(11). As a result, dietary nitrate supplementation is growing in popularity as an augmentation to exercise 
training. WHVKRZWKDWQLWUDWHLQFUHDVHV3*&Į expression and a switch from fast-twitch type IIb 
towards oxidative slow-twitch type I and intermediate type IIa fibers in both the soleus and 
gastrocnemius muscle; a phenomenon typical of exercise training, and consistent with the effects 
observed on exercise, mitochondrial fatty acid oxidation and efficiency in muscle predominately 
consisting of type I and type IIa fibers (9; 23). 
 
T2DM is accompanied by perturbations to muscle physiology, resulting in decreased mitochondrial 
content and abnormal lipid deposition, impairing the insulin-mediated switch between fat and 
carbohydrate metabolism (37). Dietary nitrate supplementation exhibits anti-obesity and anti-diabetic 
properties in rodents; improving homeostatic model assessment for insulin resistance and quantitative 
insulin sensitivity check index assessments in high-fructose diet-induced insulin resistant rats (5), and 
improving glucose tolerance in NOS-deficient mice (4); while reducing adiposity in both models. We 
have shown that nitrate increases muscle ȕ-oxidation and mitochondrial biogenesis (23), and therefore 
may have utility in treating the intramuscular lipid deposition-induced lipotoxicity and insulin resistance 
associated with diabetes. However, diabetic myopathy is a major complication of diabetes and is 
characterized by muscle atrophy and reduced physical performance and muscle capacity (20). Skeletal 
muscle from diabetic patients exhibits a higher concentration of glycolytic fibers (38), and evidence of a 
switch towards a glycolytic phenotype (39). Indeed, the proportion of muscle type I fibers is positively 
correlated with insulin sensitivity (21); and decreased levels of type I fibers are associated with insulin 
resistance (22). Relative to glycolytic fibers, oxidative fibers are more resistant to atrophy following 
denervation or aging. Since, the concentrations of nitrate utilized in this study are achievable in humans 
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following dietary intervention (4); nitrate supplementation may provide a means of stimulating exercise-
like fiber-type switching effects in the muscle of diabetic patients to treat perturbed muscle phenotypes. 
However, a small number of human trials assessing the anti-diabetic effects of short-term nitrate 
supplementation have thus far proved disappointing (40); it remains to be seen whether larger, longer-
term studies in diabetic or pre-diabetic populations (in which disease is less advanced) will demonstrate 
the beneficial effects observed in rodent models.  
 
Our data suggests that nitrate may be additive to the effects of exercise training on muscle phenotypes, 
complimenting studies by De Smet at al. showing sprint interval training, in combination with nitrate 
supplementation, increases the proportion of type IIa fibers in muscle in humans (29). Indeed, type I and 
type IIa muscle fibers are more efficient at performing, and have a greater capacity for, oxidative 
metabolism than type IIb muscle fibers (41; 42). A higher percentage of type I muscle correlates 
positively with exercise efficiency in exercise tests (43; 44); meaning that a higher percentage of type I 
muscle fibers improves endurance performance by significantly increasing the power output generated 
for a given rate of oxygen consumption and energy expenditure (43; 44). Therefore, the switching of 
muscle fibers from type IIb to types IIa and I (as we observe with nitrate supplementation) decreases the 
oxygen cost of endurance exercise, making our findings complementary to previous observations that 
dietary nitrate lowers the oxygen cost of exercise. Subsequently, nitrate-induced fiber-type switching 
likely contributes to the observed effects of nitrate on exercise.  
 
Furthermore, we identify that the nitrate-mediated induction of fiber-type switching occurs, at least in 
part, through an NO-3*&Į-dependent mechanism. Rasbach et al. identified that PGCĮLQGXFHGILEHU-
type switching requires functional, stabilized+,)Į (14). Others have demonstrate that NO functions to 
stabilize HIF (6; 28). Since, we find that nitrate-induced fiber type switching occurs without extrinsic 
HIF stabilization, our work may suggest that NO generated as a result of nitrate reduction functions to 
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stabilize +,)Į during the nitrate-3*&Į-stimulated expression of type I and type IIa fiber-type 
markers.  
 
It is worth noting that our in vitro mechanistic studies, implicating NO in nitrate-induced expression of 
fiber-type markers, were conducted in non-contracting myotubes. It will be of consequence for future 
studies to examine these mechanisms in models of exercising muscle. Moreover, while a physiological, 
enzymatic mechanism for the reduction of nitrate to NO in mammalian tissue has been suggested (2; 
45), numerous proteins have been implicated in this reductive activity (2; 12; 46; 47). In addition, nitrate 
reduction has been observed in both hypoxia and normoxia (2; 12; 45). Therefore, the mechanisms 
underlying reduction of nitrate to NO in skeletal muscle, and the involvement of NO in the downstream 
effects of nitrate, remain to be fully determined.   
 
Exercise-induced 3*&ĮH[SUHVVLRQLQVNHOHWDOPXVFOHFRQWULEXWHVWR the beneficial cardiometabolic 
effects of exercise through myokine signaling (17; 18). We find that nitrate regulates the exercise and 
3*&Į-dependent myokine FNDC5/Irisin and myokine-like small molecule BAIBA. BAIBA alters 
energy metabolism in adipose tissue and liver (17), whereas irisin stimulates the browning of adipose 
tissue (18). Here, nitrate and irisin are seen to function additively to induce brown adipocyte-specific 
gene expression in adipocytes; therefore nitrate supplementation on an exercise-trained background may 
augment the exercise-dependent activation of WAT browning. It is also reasonable to speculate that the 
nitrate-induced secondary release of myokine factors may contribute to the anti-diabetic effects of 
nitrate.  
 
8QH[SHFWHGO\WKLVVWXG\KLJKOLJKWHGD3*&ĮDQGH[HUFLVH-induced mechanism mediating muscle 
production and release of GABA. Nitrate activated this pathway, increasing circulating GABA 
concentrations in rodents and humans. Peripheral GABA increases plasma growth hormone 
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concentration in humans (35). Independently, NO signaling has been implicated as a pathway mediating 
the exercise-stimulated increase in circulating growth hormone (48), and directly increases growth 
hormone release (36). Exercise is one of the most efficacious stimuli for growth hormone secretion, 
however the exact mechanisms remain to be defined. We observe that nitrate treatment increases the 
circulating growth hormone concentration in rats and humans. Therefore, GABA may function as a 
3*&Į-dependent myokine-like small molecule signal, with biosynthesis and secretion triggered by 
both exercise and nitrate. Our investigations highlight an interaction linking NO and 3*&Į to muscle 
GABA secretion and peripheral GABA concentration, in a pathway that may contribute to exercise-
stimulated growth hormone release in the adaptive response to exercise. 
 
This investigation highlights that nitrate induces exercise training-like physiological adaptations both in 
skeletal muscle and systemically. GABA may function as an exercise and nitrate-VWLPXODWHG3*&Į-
mediated, myokine-like small molecule, and the exercise mimetic effects of nitrate may contribute to the 
beneficial effects of nitrate on both exercise and cardiometabolic health.  
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Figure Legends 
Fig 1. Inorganic Nitrate Induces Muscular Fiber-type Switching in Oxidative Muscle (A3*&Į
mRNA in nitrate treated rat soleus (t-test, n = 5). (B+,)ĮP51$LQQLWUDWHWUHDWHGUDWVROHXVW-test, n 
= 5). (C) The expression of slow and intermediate-twitch muscle fiber genes, MYH7, MYH2, CALM2, 
and the fast-twitch fiber gene, MYH4, in nitrate treated rat soleus (multiple t-test, n = 5). (D3*&Į
protein in nitrate treated rat soleus (t-test, n = 5 / group). (E) MYH7 protein concentration in nitrate 
treated rat soleus (t-test, n = 5). (F) MYH2 protein concentration in nitrate treated rat soleus (t-test, n = 
5). (G) Glucose-6-phosphate concentration in nitrate treated rat soleus (t-test, n = 9). (H) 3-
phosphoglycerate concentration in nitrate treated rat soleus (t-test, n = 9). (I) Quantitation of fiber-types 
from cross-sections of soleus immunostained for myosin heavy chains I and II (n = 5). (J) Cross-sections 
of soleus immunostained for myosin heavy chains I (black/grey), II (red) (fluorescent red) (n = 5) 
Original magnification, × 20. Data are represented as Mean ± SEM. 33. 
 
Fig 2. Inorganic Nitrate Induces Muscular Fiber-type Switching in Glycolytic Muscle (A) The 
expression of slow and intermediate-twitch muscle fiber JHQHV3*&Į+,)Į0<+0<+DQG0E
and the fast-twitch muscle fiber gene MYH4 in nitrate treated rat gastrocnemius (multiple t-test, n = 4). 
(B) Quantitation of fiber-types from cross-sections of gastrocnemius immunostained for myosin heavy 
chains I and II (n = 4). (C) Cross-sections of gastrocnemius were immunostained for myosin heavy 
chains I (black/grey), II (red) (fluorescent red) (n = 4). Original magnification, × 20. Data are 
represented as Mean ± SEM. 3 33. 
 
Fig 3. Nitrate Induces Slow-twitch Muscle Fiber Gene Expression in Myotubes (A) 3*&ĮP51$
in myotubes treated with 500 µM NaNO3 or 500 µM NaNO3 and 100 µM 2,2-Bipyridyl (one-way 
ANOVA, n = 6). (B) Expression of slow, intermediate and fast-twitch muscle fiber genes in myotubes 
treated with 500 µM NaNO3 or 500 µM NaNO3 and 100 µM 2,2-Bipyridyl (one-way ANOVA, n = 6). 
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(C) The expression of WUDQVFULSWLRQIDFWRUV3*&Į+,)ĮDQG33$5įDQG slow, intermediate and fast-
twitch muscle fiber genes in myotubes WUHDWHGZLWKQLWUDWHȝ01D123ȝ01D123), and nitrate 
and PTIO (500 ȝ01D123 + 50 ȝ0 PTIO) (one-way ANOVA, n = 6). (D) The expression of slow-
twitch muscle fiber genes is increased in myotubes treated with nitrite (NaNO2) (500 nM, 2ȝ0DQG
ȝ0 (one-way ANOVA, n = 6). (E) Expression of slow, intermediate and fast-twitch muscle fiber 
genes in myotubes treated ZLWKQ033$5įDJRQLVW*:RU01D123 and 100 nM GW742 
(one-way ANOVA, n = 4). Results of two-way ANOVA omnibus test are shown at the top of the 
graphs. Data are represented as Mean ± SEM. NS, not significant, 33 3
0.001, **** P < 0.0001.  
 
Fig 4. Nitrate-mediated Muscle Fiber-W\SH6ZLWFKLQJ)XQFWLRQVWKURXJK3*&ĮDQG6ROXEOH
Guanylyl Cyclase and is Enhanced by Sildenafil (A3*&Į expression in C2C12 myotubes treated 
with negative control siRNA or siRNA against 3*&Į with and without ȝ0DQGȝ0 NaNO3 
(one-way ANOVA, n = 3) (B) Expression of slow, intermediate and fast-twitch muscle fiber genes in 
myotubes treated with negative coQWUROVL51$RUVL51$DJDLQVW3*&Į with and without 50 and 500 
ȝ01D12(one-way ANOVA, n = 3) (C) The expression of slow, intermediate, and fast-twitch muscle 
ILEHUJHQHVLQP\RWXEHVWUHDWHGZLWKWKHJXDQ\O\OF\FODVHLQKLELWRU2'4ȝ0ZLWKDQGZLWKRXW
ȝ01D123 (one-way ANOVA, n = 6). (D) The expression of PDE5 mRNA in nitrate treated C2C12 
myotubes (t-test, n = 3). (E&&P\RWXEHVWUHDWHGZLWKWKH3'(LQKLELWRU6LOGHQDILOȝ0ZLWK
DQGZLWKRXWȝ01D123 (one-way ANOVA, n = 6). Results of two-way ANOVA omnibus test are 
shown at the top of the graphs. Data are represented as Mean ± SEM. NS, nRWVLJQLILFDQW3 ** 
3 3 **** P < 0.0001.  
 
)LJ1LWUDWH,QGXFHVWKH6HFUHWLRQRIWKH3*&Į([HUFLVH-dependent Myokine Irisin (A) 
)1'&LULVLQH[SUHVVLRQLQ&&P\RWXEHVWUHDWHGZLWKȝ01D123 with and without the NO 
scavenger PTIO (one-way ANOVA, n = 3). (B) FNDC5/irisin expression in myotubes treated with 500 
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ȝ01D123 ZLWKDQGZLWKRXWȝ06LOGHQDILORQH-way ANOVA, n = 3). (C) Irisin protein concentration 
LQWKHPHGLDRIȝ01D123 and PPARįDJRQLVW*:WUHDWHGmyotubes (one-way ANOVA, n = 
3). (D) FNDC5/irisin expression in nitrate treated rat soleus (t-test, n = 5). (E) FNDC5/irisin expression 
nitrate treated rat gastrocnemius (t-test, n = 4). (F) Plasma irisin concentration of nitrate treated rats (t-
test, n = 9). (G) Concentration of nitrogen oxides (NOx) in the serum of human volunteers preceding 
and following 7 days of treatment with nitrate ± containing beetroot juice (paired t-test, n = 18). (H) 
Irisin protein concentration in the serum of human volunteers preceding and following 7 days of 
treatment with nitrate ± containing beetroot juice (paired t-test, n = 18). Data are represented as Mean ± 
6(033331. 
 
Fig 6. Nitrate Induces the S\QWKHVLVDQG6HFUHWLRQRIWKH3*&Į([HUFLVH-dependent Myokine-like 
Small Molecule ȕ-aminoisobutyric acid (A) BAIBA concentration in C2C12 myotubes treated with 
ȝ01D123 (t-test, n = 3). (B) BAIBA concentration in serum-free conditioned media from C2C12 
P\RWXEHVWUHDWHGZLWKȝ01D123 (t-test, n = 3). (C) The expression of BAIBA biosynthetic genes 
$&$'6DQG+$'+$LQ&&P\RWXEHVWUHDWHGZLWKȝ01D123 with and without the NO 
scavenger PTIO (one-way ANOVA, and two-way ANOVA omnibus test above graph, n = 3). (D) 
BAIBA concentration in soleus skeletal muscle of 0.7 mM NaNO3 treated rats (t-test, n = 9). (E) The 
expression of BAIBA biosynthetic genes ACADS and HADHA mRNA in the soleus of nitrate treated 
rats (two-way ANOVA, n = 5). (F) Plasma BAIBA from 0.7 mM NaCl or 0.7 mM NaNO3 treated rats 
(t-WHVWQ 'DWDDUHUHSUHVHQWHGDV0HDQ6(0333 
 
 
Fig 7. Nitrate Increases Circulating Ȗ-Aminobutyric Acid and Growth Hormone Concentrations 
(A) Plasma GABA and (B) glutamine concentrations in 0.7 mM NaCl or 0.7 mM NaNO3 treated rats (t-
test, n = 9). (C) Serum GABA and (D) glutamine concentration of participants following 7 days of 
nitrate±containing beetroot juice supplementation (paired t-test, n = 18). (E) Plasma GABA 
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FRQFHQWUDWLRQIURPPXVFOHVSHFLILF3*&ĮWUDQVJHQLFPLFHFRPSDUHGWRDJHPDWFKHGFRQWUROPLFHt-
test, n = 5/group). (F*$%$FRQFHQWUDWLRQLQWKHPHGLDRIȝ01D123 and 100 nM PPARįDJRQLVW
GW742 treated myotubes (one-way ANOVA, n = 3). (G) Intracellular GABA concentration in 500 µM 
NaNO3 treated myotubes (t-test, n = 3). (H) Plasma, (I) gastrocnemius, and (J) quadriceps GABA 
concentrations of mice subjected to 3 weeks of free wheel running (t-test, n = 6) or sedentary controls (n 
= 6). (K) Plasma growth hormone concentration of nitrate treated rats (t-test, n = 9) (L) Serum growth 
hormone concentration of participants following 7 days of nitrate±containing beetroot juice 
supplementation (paired t-test, n = 18). Data are represented as Mean ± SEM. *, P 3
3 
